Jazz’ small cell lung cancer therapy wins US green light
The approval gives patients who relapse a new second-line option for the first time in nearly 20 years
Read More
Tag: lurbinectedin
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
